{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:33:07Z","timestamp":1697419987854},"reference-count":36,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":54,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>1.\u2002Arginine vasopressin (AVP) has been reported to be involved in the development of cerebral vasospasm after haemorrhage and cerebral oedema following ischaemia. Endogenously produced 5\u2010lipoxygenase metabolites are able to contract isolated endothelium\u2010preserved arterial strips and modulate vascular permeability. The present study addresses the role of 5\u2010lipoxygenase and its products, namely cysteinyl leukotrienes (CysLTs) and leukotriene (LT) B<jats:sub>4<\/jats:sub>, in the contraction induced by AVP in rat basilar artery.<\/jats:p><jats:p>2.\u2002Contractile responses to LTD<jats:sub>4<\/jats:sub>, LTC<jats:sub>4<\/jats:sub>, LTB<jats:sub>4<\/jats:sub> or AVP were assessed in spiral preparations of rat endothelium\u2010intact basilar artery. Contractions to AVP were determined in the absence or presence of 5\u2010lipoxygenase inhibitors or CysLT<jats:sub>1<\/jats:sub> or BLT receptor antagonists. Contractile responses to leukotrienes and AVP are expressed as a percentage of the contraction induced by 80\u00a0mmol\/L KCl.<\/jats:p><jats:p>3.\u2002Leukotriene D<jats:sub>4<\/jats:sub>, LTC<jats:sub>4<\/jats:sub> and LTB<jats:sub>4<\/jats:sub> acted as vasoconstrictor agents in rat basilar artery, causing contractions (all at concentrations of 1\u00a0\u00b5mol\/L) of 42\u00a0\u00b1\u00a013, 54\u00a0\u00b1\u00a015 and 25\u00a0\u00b1\u00a06% of the response to 80\u00a0mmol\/L KCl, respectively. A concentration\u2013response curve was constructed for AVP over the range 1\u00a0pmol\/L to 10\u00a0nmol\/L and an EC<jats:sub>50<\/jats:sub> value of 0.19\u00a0\u00b1\u00a00.02\u00a0nmol\/L (<jats:italic>n<\/jats:italic>\u00a0=\u00a030) was determinted. The presence of the 5\u2010lipoxygenase inhibitors ZM\u00a0230487 (10\u00a0nmol\/L and 0.1 and 1\u00a0\u00b5mol\/L) and AA\u00a0861 (1, 3, 10, and 30\u00a0\u00b5mol\/L), the CysLT<jats:sub>1<\/jats:sub> receptor antagonist MK\u00a0571 (3, 10 and 30\u00a0\u00b5mol\/L) or the BLT receptor antagonists CP\u00a0105696 and LY\u00a0255283 (3, 10 and 30\u00a0\u00b5mol\/L for both) in the organ bath significantly attenuated the contractions induced by AVP in rat basilar artery (<jats:italic>P<\/jats:italic>\u00a0&lt; 0.05).<\/jats:p><jats:p>4.\u2002The experimental results of the present study provide the first evidence for the involvement of CysLTs and LTB<jats:sub>4<\/jats:sub> in the <jats:italic>in vitro<\/jats:italic> constriction induced by AVP in rat basilar artery. In the context of previously reported involvement of AVP in the development of cerebral vasospasm and oedema, the present study draws attention to the potential role played by the 5\u2010lipoxygenase pathway in these pathological processes.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2005.04300.x","type":"journal-article","created":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T13:30:08Z","timestamp":1138109408000},"page":"1027-1033","source":"Crossref","is-referenced-by-count":5,"title":["Cysteinyl leukotrienes and leukotriene B<sub>4<\/sub> mediate vasoconstriction to arginine vasopressin in rat basilar artery"],"prefix":"10.1111","volume":"32","author":[{"given":"Cristina C","family":"Trandafir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nishihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(02)39017-4"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-0404.2003.00245.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.44.3.216"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.1995.11758611"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15613.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)00781-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(00)00304-0"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.01.051"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2004.03986.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(95)00009-Q"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1993.1077"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mva.1990.21688"},{"key":"e_1_2_6_14_2","first-page":"763","article-title":"Leukotriene biosynthesis by canine and human coronary arteries","volume":"241","author":"Piomelli D","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.24.2406"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.2.200"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705087"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.281.1.H342"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00238-8"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.2168"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000028008.99774.7F"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242716099"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1311"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000082690.23131.CB"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/21658"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00699.2003"},{"key":"e_1_2_6_27_2","first-page":"259","article-title":"Early changes of endothelin, nitric oxide and arginine\u2010vasopressin in patients with acute cerebral injury","volume":"5","author":"Yang Y","year":"2002","journal-title":"Chin. J. Traumatol."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01285.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.11.049"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)39144-6"},{"key":"e_1_2_6_31_2","first-page":"1249","article-title":"Reperfusion induces 5\u2010lipoxygenase translocation and leukotriene C4 production in ischemic brain","volume":"268","author":"Ohtsuki T","year":"1995","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1988.tb03077.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-3278(03)00073-5"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.55.1.8"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.11.6155"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(01)00774-2"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000039405.31526.06"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2005.04300.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2005.04300.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2005.04300.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1440-1681.2005.04300.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2005.04300.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T10:49:49Z","timestamp":1694256589000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2005.04300.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1440-1681.2005.04300.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2005.04300.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}